These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 546740)

  • 1. Effect of host sensitization to tumour on splenic depletion & recovery following severe immunosuppressive treatment.
    Poduval TB; Seshadri M; Ray PK; Thakur VS; Sundaram K
    Indian J Exp Biol; 1979 Oct; 17(10):1064-7. PubMed ID: 546740
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrocortisone affects tumor growth by eliminating precursors of suppressor cells.
    Schechter B; Feldman M
    J Immunol; 1977 Nov; 119(5):1563-8. PubMed ID: 915269
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical immunodepression: role of splenic suppressor cells.
    Yamagishi H; Pellis NR; Kahan BD
    Surg Forum; 1978; 29():465-8. PubMed ID: 162609
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 5. An assessment of the immunosuppressive activity of the anti-tumour compound--4'-((9-acridinyl)amino)methanesulphon-m-anisidide (m-AMSA).
    Baguley GC; Falkenhaug EM; Rastrick JM; Marbrook J
    Eur J Cancer (1965); 1974 Mar; 10(3):169-75. PubMed ID: 4609763
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stimulation of antitumor immunity in vivo using the RNA isolated from the splenic cells of tumor-bearing mice].
    Mesropian NP; Balabadzhian NG
    Zh Eksp Klin Med; 1978; 18(4):49-51. PubMed ID: 706890
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of immunologic activity of host in radiotherapy].
    Tsuchiya T
    Gan No Rinsho; 1983 Oct; 29(13):1499-505. PubMed ID: 6608014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression with thyminalkylamine (Ypenyl Spofa): effect on antibody plaque-forming spleen cells.
    Bohunická E; Koza I; Kuzela S; Krempaský V; Ujházy V
    Neoplasma; 1972; 19(5):499-505. PubMed ID: 4404912
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of graft-versus-host reaction in mice by picogram quantities of highly purified spleen-derived immunosuppressive peptide.
    Millerioux-Di Giusto L; Kiger N; Duchange N; Lenfant M
    Transplantation; 1981 Feb; 31(2):147-9. PubMed ID: 7020177
    [No Abstract]   [Full Text] [Related]  

  • 12. [Increase in the activity of spleen cell-suppressors in mice during tumor growth].
    Gambarov SS; Petrov RV; Khaitov RM; Norimov ASh
    Dokl Akad Nauk SSSR; 1975 Oct; 224(5):1195-7. PubMed ID: 1239360
    [No Abstract]   [Full Text] [Related]  

  • 13. Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: affinity chromatography on insolubilized histamine.
    Schechter B; Segal S; Feldman M
    J Immunol; 1978 Apr; 120(4):1268-73. PubMed ID: 641348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response].
    Spasokukotskiĭ AL
    Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible mechanism of tumor regression in cisplatin-treated mice.
    Sarna S; Sodhi A; Bhola RK
    Pol J Pharmacol Pharm; 1989; 41(1):69-76. PubMed ID: 2587438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor resistance in immunizing animals with normal syngeneic tissues].
    Fel' VIa; Malygin AM; Liepa BL; Ivanov VA
    Vopr Onkol; 1974; 20(2):40-5. PubMed ID: 4373910
    [No Abstract]   [Full Text] [Related]  

  • 18. Halothane-induced suppression of cell-mediated immunity in normal and tumor-bearing C3Hf/He mice.
    Lewis RE; Cruse JM; Hazelwood J
    Anesth Analg; 1980 Sep; 59(9):666-71. PubMed ID: 7191225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice.
    Kruisbeek AM; Sharrow SO; Mathieson BJ; Singer A
    J Immunol; 1981 Nov; 127(5):2168-76. PubMed ID: 6975310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-related syngeneic skin graft rejection in gross leukemia.
    Mariani T; Maruyama Y; Good RA
    Natl Cancer Inst Monogr; 1972 Dec; 35():309-20. PubMed ID: 4572830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.